NCT04861298 Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early Mild Symptoms of COVID-19 Status COMPLETED Phase NA
NCT04859244 First-in-Human Study of Orally Administered GS-441524 for COVID-19 Status COMPLETED Phase PHASE1
NCT04854928 Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection. Status UNKNOWN Phase PHASE2
NCT04854759 The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms Status UNKNOWN Phase PHASE3
NCT04852705 A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19) Status UNKNOWN Phase PHASE3
NCT04852289 A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04849611 Covid-19 Fear and Compliance With Protective Measures of Students Status COMPLETED Phase N/A
NCT04848584 Pfizer-BioNTech COVID-19 Vaccine Effectiveness Study - Kaiser Permanente Southern California Status COMPLETED Phase N/A
NCT04847687 Investigation of Hospitalisation Times and Mortality According to Drug Dose in Patients Given Systemic Methylprednisolone With a Pre-diagnosis of Covid-19 Pneumonia; Retrospective Study Status COMPLETED Phase N/A
NCT04847375 Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients Status UNKNOWN Phase NA
NCT04847141 A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients Status TERMINATED Phase PHASE3
NCT04847102 A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above Status UNKNOWN Phase PHASE3
NCT04844515 The ESPERES Prospective Cohort of Healthcare Workers in France: Study on COVID-19 Vaccine and the COVID-19 Pandemic (ESPERES_COVID19) Status UNKNOWN Phase N/A
NCT04844307 Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups Status WITHDRAWN Phase NA